Human Parechovirus Infection and Type 1 Diabetes

Strategic Insights -

Researchers have investigated a possible association between human parechovirus infections in early infancy and the development of islet autoimmunity. In a study published in Pediatric Diabetes, the researchers analyzed stool samples from 27 children who developed islet autoimmunity and 53 matched controls. The study found no significant difference in the prevalence of human parechovirus in stool samples between cases and controls, with 13.0% and 11.1%, respectively. Additionally, there was no difference in the number of infection episodes between the two groups.

Key Takeaways:

  • The study found no significant association between human parechovirus infections and the development of islet autoimmunity.
  • The researchers suggested a weak association between human parechovirus infections and the development of autoimmunity, warranting further investigation.
  • Human parechovirus 1 was the dominant genotype in a subset of positive samples.
  • No symptoms were associated with human parechovirus infection.
  • The study did not support strong associations between human parechovirus infections and the development of islet autoimmunity.

Statistics:

  • 27 children who developed islet autoimmunity
  • 53 matched control children
  • 13.0% of stool samples from cases were positive for human parechovirus
  • 11.1% of stool samples from controls were positive for human parechovirus
  • 3.2 odds ratio (OR) for the association between human parechovirus infections and the development of autoimmunity

Sources:

  • Tapia, G., et al. "Longitudinal study of parechovirus infection in infancy and risk of repeated positivity for multiple islet autoantibodies: the MIDIA study." Pediatric Diabetes, 2011;12(1):58-62.